Dr Arunkumar Subramanian
- Post-Doctoral Research Fellow
- School of Pharmacy
Biography
Dr Arunkumar Subramanian is a researcher specializing in neuropharmacology and translational drug discovery, with a focus on bioactive compounds such as resveratrol derivatives and Schiff base molecules for Alzheimer’s disease, obesity, and the gut microbiome. He integrates in-silico methods, including molecular docking, dynamics, and network pharmacology, with in-vitro and in-vivo validation.
He has expertise in preclinical studies using rodent and zebrafish models to assess therapeutic efficacy, toxicity, and underlying mechanisms. His work emphasizes multi-target strategies to bridge computational predictions with clinically relevant outcomes.
Academic & Professional Qualifications
- Bachelor of Pharmacy, Vinayaka Missions Research Foundation, India (2017)
- Master of Pharmacy (Pharmacology), The Tamilnadu Dr. MGR Medical University, India (2020)
- PhD (Pharmacy), SRM Institute of Science and Technology, India, (2025)
Research Interests
- Neuropharmacology
- Gut microbiome
- Drug discovery
- Preclinical Research
- Gut Brain Axis
Teaching Areas
- Pharmacology
- Toxicology
- Biochemistry
- Medicinal Chemistry
Notable Publications
VS A, Subramanian A, Rajendran K, Thamaraikani T, Kumarasamy V, Lian MS, Nordin RB, Sekar M, Subramaniyan V, Karnam M, Sackiriyas S, Wong LS, “Fructose consumption and metabolic hypertension in rats: a systematic review and meta analysis”, PeerJ., 13, e20097, 2025.
Dutta S, Subramanian A, Kumarasamy V, Tamilanban T, Begum MY, Sekar M, Subramaniyan V, Gan SH, Wong LS, Al Fatease A, Wu YS, Muralikrishnan A. “Network
Pharmacology of Natural Polyphenols for Stroke: A Bioinformatic Approach to Drug Design”, Adv Appl Bioinform Chem., 17, pp. 203-219, 2025.Deepalakshmi M, Sudharsan M, Rajalakshmi S, Boopathi D, Suganya P, Subramanian A, Rajamohamed H. “Drug-induced acneiform breakout in a postpartum psychosis patient: A case report with literature review”, Journal of Pharmacology and Pharmacotherapeutics. 2025.
A. Subramanian, T. Tamilanban, A. D. I. Abdullah, V. Chitra, M. Sekar, G. Swaminathan, I. Yadav, V. Manimaran, V. Rajakumari, and V. Subramaniyan, "Safety assessment of resveratrol surrogate molecule 5 (RSM5): Acute and sub-acute oral toxicity studies in BALB/c mice", Toxicol. Rep., 14, pp. 101956, 2025.
F. Bistagnino, A. Subramanian, and M. R. Tovani Palone, "Navigating the (post-) pandemic landscape: An analysis of COVID-19’s current status and future implications", Disaster Med. Public Health Prep., 19, pp. e44, 2025.
A. Subramanian, R. Haitharali, N. S., T. Tamilanban, S. Dhanasekaran, S. Gnanasekaran, M. Manavalan, and S. Raja, "Carbamazepine-induced Stevens Johnson Syndrome: A case report with review of the literature", Current Drug Safety, 20(3):382-387, 2025.
A. Subramanian, V. Kumarasamy, M. Y. Begum, M. Sekar, V. Subramaniyan, L. S. Wong, and A. Al Fatease, "Exploring the connections: Autophagy, gut microbiota, and inflammatory bowel disease pathogenesis", J. Inflamm. Res., 17, pp. 10453–10470, 2024.
A. Subramanian, T. Tamilanban, V. Subramaniyan, M. Sekar, V. Kumar, A. K. Janakiraman, and S. Kayarohanam, "Establishing network pharmacology between natural polyphenols and Alzheimer’s disease using bioinformatic tools–an advancement in Alzheimer’s research", Toxicol. Rep., 13, pp. 101715, 2024.
A. Subramanian, J. Mohanbabu, T. Srinivasan, T. Tamilanban, V. Subramaniyan, V. Manimaran, M. Sekar, and L. S. Wong, "Reviewing the literature of 3D printing of bones and cartilage: Evidence and practice", Ann. 3D Print. Med., 16, pp. 100180, 2024.
A. Reshma, A. Subramanian, V. Kumarasamy, T. Tamilanban, M. Sekar, S. H. Gan, V. Subramaniyan, L. S. Wong, N. N. I. M. Rani, and Y. S. Wu, "Neurocognitive effects of proanthocyanidin in Alzheimer’s disease: A systematic review of preclinical evidence", Braz. J. Med. Biol. Res., 57, pp. e13587, 2024.
